Pancreatic Ductal Adenocarcinoma (PDAC) trials recruiting in California
All Pancreatic Ductal Adenocarcinoma (PDAC) trials nationally
10
Recruiting in California
8
Cities with sites
Cities in California
Los Angeles 3Duarte 2La Jolla 1Orange 1Sacramento 1San Diego 1San Francisco 1Santa Monica 1
Recruiting trials in California
- A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
- A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
- A Study of MT-4561 in Patients With Various Advanced Solid Tumors
- A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
- Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer
- Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors